Growth modulation index (GMI) as a comparative efficacy measure of larotrectinib versus prior systemic treatments for TRK fusion cancer patients Meeting Abstract
| Authors: | Italiano, A.; Hong, D. S.; Briggs, A.; Garcia-Foncillas, J.; Lassen, U. N.; Vassal, G.; Kummar, S.; Van Tilburg, C. M.; Keating, K. N.; Reeves, J. A.; Fellous, M. M.; Childs, B. H.; Laetsch, T. W.; Drilon, A. E. |
| Abstract Title: | Growth modulation index (GMI) as a comparative efficacy measure of larotrectinib versus prior systemic treatments for TRK fusion cancer patients |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Language: | English |
| ACCESSION: | WOS:000560368305341 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.e15638 |
| Notes: | Meeting Abstract: e15638 -- Source: Wos |
